You have searched for "Bottle"
Showing 41-50 of 10000
BRUSSELS (Reuters) - The European Union could give final approval for the Pfizer-BioNTech COVID-19 vaccine as early as Dec. 23, a senior Commission official said on Wednesday, only two days after a possible green light from the bloc's regulator.
RESIDENTS representatives from Desa Mentari flats, Petaling Jaya have been briefed on ways to ensure a safe environment as the fight against Covid-19 continues.
CAPE TOWN (Reuters) - South Africa wing Aphiwe Dyantyi has been handed a four-year ban for doping after failing to prove that he took multiple performance-enhancing drugs in error, officials confirmed on Monday.
(Reuters) - The $2.3 trillion COVID-19 aid and spending package signed by U.S. President Donald Trump buoyed the stock and oil markets on Monday, while more countries detected their first cases of a new variant of the coronavirus.
An exclusive and iconic decanter marks Hennessy X.O’s 150th anniversary this year.
(Reuters) - The first shots in a massive U.S. COVID-19 vaccine campaign will be administered as early as Monday, with Pfizer Inc and partners aiming to start shipments across the hard-hit country on Sunday, an Army general organizing the rollout said.
RESIDENTS’ representatives of flats in Desa Mentari, Petaling Jaya were briefed on ways to ensure a safe environment as the fight against the spread of Covid-19 continues.
BETTER days are in store for security guard S. Paner Selvam, 38, his wife and three young children who live in deplorable conditions in a rented room in a house shared with 28 other tenants.
The country has approved Advanced MedTech Holdings’ Covid-19 kit for use in testing saliva from deep within the throat, the company said, as the country looks to ramp up testing to help reopen its borders and resume more economic activity.
More women than men in U.S. nervous about fast rollout of COVID vaccine, and that's a problem: Reuters/Ipsos poll
NEW YORK (Reuters) - American women, who traditionally make most of the healthcare decisions in their families, are more wary than men of the new, rapidly developed COVID-19 vaccines, according to a Reuters/Ipsos poll, presenting a potential challenge to efforts to immunize the public.